Michael Petusky
Stock Analyst at Barrington Research
(2.25)
# 2,738
Out of 5,182 analysts
238
Total ratings
39.63%
Success rate
-1.85%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMSI Merit Medical Systems | Maintains: Outperform | $109 → $107 | $66.74 | +60.32% | 27 | Apr 20, 2026 | |
| OFIX Orthofix Medical | Maintains: Outperform | $17 | $11.92 | +42.62% | 7 | Apr 10, 2026 | |
| LFCR Lifecore Biomedical | Maintains: Outperform | $5.5 | $5.12 | +7.42% | 9 | Mar 27, 2026 | |
| BVS Bioventus | Maintains: Outperform | $13 → $14 | $9.95 | +40.70% | 2 | Mar 6, 2026 | |
| OPK OPKO Health | Maintains: Outperform | $2.25 → $1.5 | $1.21 | +23.97% | 16 | Mar 2, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $14 → $17 | $11.78 | +44.31% | 28 | Mar 2, 2026 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $16 → $17 | $15.29 | +11.18% | 22 | Feb 27, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 → $105 | $112.40 | -6.58% | 15 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Outperform | $79 → $97 | $76.12 | +27.43% | 19 | Feb 25, 2026 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $103 | $72.54 | +41.99% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $94 | $59.84 | +57.09% | 36 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $42 | $27.77 | +51.24% | 19 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1 → $1.5 | $0.81 | +85.19% | 11 | Jan 6, 2026 |
Merit Medical Systems
Apr 20, 2026
Maintains: Outperform
Price Target: $109 → $107
Current: $66.74
Upside: +60.32%
Orthofix Medical
Apr 10, 2026
Maintains: Outperform
Price Target: $17
Current: $11.92
Upside: +42.62%
Lifecore Biomedical
Mar 27, 2026
Maintains: Outperform
Price Target: $5.5
Current: $5.12
Upside: +7.42%
Bioventus
Mar 6, 2026
Maintains: Outperform
Price Target: $13 → $14
Current: $9.95
Upside: +40.70%
OPKO Health
Mar 2, 2026
Maintains: Outperform
Price Target: $2.25 → $1.5
Current: $1.21
Upside: +23.97%
DENTSPLY SIRONA
Mar 2, 2026
Maintains: Outperform
Price Target: $14 → $17
Current: $11.78
Upside: +44.31%
Anika Therapeutics
Feb 27, 2026
Maintains: Outperform
Price Target: $16 → $17
Current: $15.29
Upside: +11.18%
LeMaitre Vascular
Feb 26, 2026
Maintains: Outperform
Price Target: $95 → $105
Current: $112.40
Upside: -6.58%
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $79 → $97
Current: $76.12
Upside: +27.43%
U.S. Physical Therapy
Feb 20, 2026
Maintains: Outperform
Price Target: $103
Current: $72.54
Upside: +41.99%
Feb 6, 2026
Maintains: Outperform
Price Target: $93 → $94
Current: $59.84
Upside: +57.09%
Jan 16, 2026
Maintains: Outperform
Price Target: $38 → $42
Current: $27.77
Upside: +51.24%
Jan 6, 2026
Maintains: Outperform
Price Target: $1 → $1.5
Current: $0.81
Upside: +85.19%